Radha A. Savitala Brings Expert Guidance in Healthcare Legal and Business Operations to Fight Mesothelioma.

LOS ANGELES , CALIFORNIA , UNITED STATES, August 16, 2016 /EINPresswire.com/ -- The Pacific Mesothelioma Center (PMC) at The Pacific Heart, Lung & Blood Institute (PHLBI) has announced the appointment of Radha A. Savitala, to its board of directors. Radha is a highly sought-after Los Angeles attorney with broad expertise in healthcare legal and business operations. She is currently Deputy General Counsel with Prime Healthcare Management, Inc. an award-winning hospital management company.

“I am excited to be able to contribute to this non-profit medical research organization. My passion is to help the community and their focus on mesothelioma is a great cause for which to raise funds and awareness” Radha commented upon accepting the invitation to join the board. “It is an honor to work with the team at PMC and help share the progress being made on their mesenchymal stem cell research program that will help us treat and someday cure this disease. PMC is an organization that makes a difference by bringing cutting-edge research to the bedside of patient care while providing vital support and hope to the mesothelioma victims and their families”.

Radha has worked for Prime Healthcare Management since 2007 and provides advice and counsel to board members and senior executives concerning a wide array of legal issues relative to for-profit and non-profit hospitals, medical groups, clinics and Accountable Care Organizations (ACO’s).

“Radha has extensive experience in executive leadership within the healthcare industry, and will bring a breadth of perspective and insight to our research organization, and will be a valuable addition to our board” said Rhonda Ozanian, chair of the board of directors at the PMC.

About The Pacific Mesothelioma Center:

The Pacific Heart, Lung & Blood Institute (PHLBI), a 501(c)(3) is a non-profit medical research institute established in 2002. One of the divisions, The Pacific Mesothelioma Center (PMC) is focused on the treatment and prevention of malignant pleural mesothelioma (MPM). The exploration of innovative ideas forms the foundation of PMC’s unique research program and provides the promise of future treatment breakthroughs. PMC is dedicated to educating the public on asbestos-related diseases and informing them of their best treatment options. PMC also connects newly diagnosed patients with patients that have been through treatment and provides assistance and emotional support.

Clare Cameron
The Pacific Heart, Lung & Blood Institute
310-478-4678
email us here